-
Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trialCatalano, M. ...Objective: To assess the prophylactic efficacy of aspirin and a high-dose antioxidant vitamin combination in patients with peripheral arterial disease (PAD) in terms of reduction of the risk of a ... first vascular event (myocardial infarction, stroke, vascular death) and critical limb ischaemia. Design: Randomized, placebo-controlled, double-blind clinical trial with 2 x 2 factorial design. Seting: Thirty-seven European angiology/vascular medicine units. Subjects: A total of 366 outpatients with stage I-II PAD documented by angiography or ultrasound, with ankle/brachial index <0.85 or toe index <0.6; 210 patients completed the follow-up. Iterventions: Four treatment groups: (i)oral aspirin (100 mg daily), (ii) oral antioxidant vitamins (600 mg vitaminE, 250 mg vitamin C and 20 mg beta-carotene daily), (iii) both or (iv) neither, given for 2 years. Main outcome measure: Major vascular events (cardiovascular death, myocardial infarction or stroke) and critical leg ischaemia. Results: Seven of 185 patients allocated aspirin and 20 of 181 allocated placebo suffered a major vascular event (risk reduction 64%, P = 0.022); five and eight patients, respectively, suffered critical leg ischaemia(total 12 vs. 28, P = 0.014). There was no evidence that antioxidant vitamins were beneficial (16/185 vs. 11/181 vascular events). Neither treatment was associated with any significant increase in adverse events. Inclusion of this trial in a meta-analysis of other randomized trials of anti-platelet therapy in PAD makes the overall results highly significant (P <0.001) and suggests that low-dose aspirin reduces the incidence of vascular events by 26%. Conclusions: For the first time direct evidence shows that low-dose aspirin should routinely be considered for PAD patients, including those with concomitant type 2 diabetes.Source: Journal of internal medicine. - ISSN 0954-6820 (Letn. 261, št. 3, 2007, str. 276-284)Type of material - article, component partPublish date - 2007Language - englishCOBISS.SI-ID - 22939609
Author
Catalano, M. |
Kozak, Matija |
Mavri, Alenka
Topics
Aspirin |
Peripheral Vascular Diseases |
Antioxidants |
Vitamins |
Myocardial Infarction |
Cerebral Infarction |
Ischemia |
Leg |
Randomized Controlled Trials |
Multicenter Studies |
Antioksidanti |
Aspirin |
Miokardni infarkt |
Periferne žile, bolezni |
Vitamini |
Ishemija |
Možganski infarkt |
Naključno kontrolirane, klinične preiskave |
Noga |
Policentrične študije
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Catalano, M. | ![]() |
Kozak, Matija | 05965 |
Mavri, Alenka | 14642 |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
Pickup location | Material status | Reservation |
---|
Please wait a moment.